Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darqeen Capsule for Hypothyroidism
NCT06826248Phase 1Active, not recruiting
- Sponsor
- Hamdard University
- Start
- Jul 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of l-ornithine l-aspartate in hypothyroidism, sponsored by Hamdard University. Primary endpoint: Thyroid Stimulating Hormone at 12 weeks. Started Jul 2024; status: active, not recruiting.
02
Drugs
l-ornithine l-aspartate
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT06826248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06826248.